Fibromyalgia Very Often Misdiagnosed as ADHD, Says Blood Test Maker EpicGenetics

Fibromyalgia Very Often Misdiagnosed as ADHD, Says Blood Test Maker EpicGenetics
Eighty percent of thousands of people younger than 19 were misdiagnosed with attention deficit hyperactivity disorder (ADHD) before being tested for fibromyalgia, according to EpicGenetics, a company that developed the first blood test approved (2012) by the U.S. Food and Drug  Administration (FDA) for fibromyalgia. Requiring less than an ounce of blood, the multi-biomarker-based test, the FM/a Test, examines white blood cells’ protein production and identifies fibromyalgia-related immune system abnormalities. Considering there are about 6.4 million children 4-17 years old with an ADHD diagnosis, there is a high probability that a large percentage of those patients have been misdiagnosed and prescribed ADHD-related drugs,  which can be harmful when taken for too long. To help prevent a misdiagnosis of ADHD in children, EpicGenetics is going to offer the FM/a Test with a 50 percent discount to any child. “We need to stop treating symptoms, and first determine the correct diagnosis before prescribing drugs," Bruce Gillis, MD, CEO of EpicGenetics, said in a press release. "By helping to diagnose children’s ailments accurately, we can provide them with a healthier, safer future." Studies suggest that pain-modulating brain chemical messengers such as dopamine, noradrenaline and serotonin, play a role in fibromyalgia disease mechanism. Fibromyalgia usually is a diagnosis of exclusion. That is because disease symptoms are similar to those of several other disorders. Besides chronic pain, patients often complain of difficulty with concentration and attention, forgetfulness, and problems with word-finding and word fluency. Mostly diagnosed in childhood, ADHD also is associated with impaired cognition and, like fibromyalgia, thought to be related t
Subscribe or to access all post and page content.